MIN-117
id:
min-117-308-17499861
title:
MIN-117
text:
MIN-117 is an investigational antidepressant which is under development by Minerva Neurosciences for the clinical treatment of major depressive disorder (MDD). It is described as a 5-HT1A and 5-HT2A receptor antagonist and inhibitor of serotonin and dopamine reuptake, and is also reported to possess affinity for the α1A- and α1B-adrenergic receptors. As of May 2015, MIN-117 is in phase II clinical trials for MDD. In December 2019, Minerva announced that MIN-117 was no longer in clinical developm
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/MIN-117
date created:
date modified:
2024-01-27T09:56:58Z
main entity:
{"identifier":"Q20706886","url":"https://www.wikidata.org/entity/Q20706886"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/5/5b/MIN-117.svg","width":2075,"height":965}
fields total:
13
integrity:
15